PENN PHARMACEUTICALS HOLDINGS LIMITED

Company Number		04294120
Date formed		2001-09-26
Country		UNITED KINGDOM
Origin Country		United Kingdom
Type		Private Limited Company
CompanyStatus		Dissolved
Lastest accounts		2015-06-30
Date Dissolved		2018-04-03
Type of accounts		FULL

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of PENN PHARMACEUTICALS HOLDINGS LIMITED

Current Directors

Officer	Role	Date Appointed
CAPITAL LAW AND PEOPLE LIMITED	Company Secretary	2015-09-14
MITCHELL ERIC BLUMENFELD	Director	2016-07-01
REMY HAUSER	Director	2016-07-01
SUJIT JOHN	Director	2016-07-01
WILLIAM T MITCHELL, III	Director	2015-05-12

Previous Officers

Officer	Role	Date Appointed	Date Resigned
PHILLIP CUMMINS	Director	2015-05-12	2016-07-01
NATHAN ROBERT EVERY	Director	2015-05-12	2016-07-01
ALAN DAVID FRAZIER	Director	2015-05-12	2016-07-01
JOSEPH EDWARD WHITTERS	Director	2015-05-12	2016-07-01
TACHI YAMADA	Director	2016-01-06	2016-07-01
WILLIAM STEPHEN L WHATMORE	Director	2015-05-12	2016-01-06
REED SMITH CORPORATE SERVICES LIMITED	Company Secretary	2015-05-12	2015-08-07
MARK DEAN-NETSCHER	Director	2011-05-16	2015-05-12
RICHARD JOHN YARWOOD	Director	2010-11-26	2015-05-12
CRAIG COLLINGWOOD	Company Secretary	2012-04-02	2014-11-14
CRAIG COLLINGWOOD	Director	2012-04-02	2014-11-14
PHILLIP CUMMINS	Director	2014-05-12	2014-05-12
LEE MAINWARING	Company Secretary	2005-01-01	2012-02-22
LEE MAINWARING	Director	2007-04-25	2012-02-22
PAUL SPENCER THOMAS	Director	2007-04-25	2010-12-31
DAVID WILLIAM COOPER	Director	2010-11-26	2010-12-19
DARREN PETER HASSEY	Director	2009-08-18	2010-03-17
PETER LUTZ GEORGE	Director	2007-01-09	2010-01-11
DAVID GREIG HENDERSON	Director	2002-04-25	2007-04-25
CRAIG ROBERT RENNIE	Director	2001-11-16	2007-04-25
DAVID GREIG HENDERSON	Company Secretary	2002-04-25	2004-12-31
JEREMY RICHARD GRANVILLE HYDE	Director	2001-11-16	2004-12-03
SIMON NICHOLAS INCHLEY	Director	2001-11-16	2004-12-03
GLYN MICHAEL TONGE	Director	2001-11-16	2003-09-30
RICHARD BRYN WILLIAMS	Company Secretary	2001-11-16	2002-04-25
RICHARD BRYN WILLIAMS	Director	2001-11-16	2002-04-25
A B & C SECRETARIAL LIMITED	Nominated Secretary	2001-09-26	2001-11-16
INHOCO FORMATIONS LIMITED	Nominated Director	2001-09-26	2001-11-16

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
CAPITAL LAW AND PEOPLE LIMITED	PIONEER UK MIDCO 1 LIMITED	Company Secretary	2016-07-01	CURRENT	2016-06-01	Active
CAPITAL LAW AND PEOPLE LIMITED	PIONEER UK MIDCO 2 LIMITED	Company Secretary	2016-07-01	CURRENT	2016-06-02	Active
CAPITAL LAW AND PEOPLE LIMITED	PIONEER UK HOLDINGS LIMITED	Company Secretary	2016-07-01	CURRENT	2016-06-02	Active
CAPITAL LAW AND PEOPLE LIMITED	PENN PHARMACEUTICAL SERVICES LIMITED	Company Secretary	2015-09-16	CURRENT	1977-09-26	Active
CAPITAL LAW AND PEOPLE LIMITED	PENN LIMITED	Company Secretary	2015-09-14	CURRENT	2007-06-05	Dissolved 2017-02-28
CAPITAL LAW AND PEOPLE LIMITED	BIOTEC CLINICAL SUPPLIES LIMITED	Company Secretary	2015-09-14	CURRENT	2003-03-25	Dissolved 2017-02-28
CAPITAL LAW AND PEOPLE LIMITED	BIOTEC DISTRIBUTION, WALES LIMITED	Company Secretary	2015-09-14	CURRENT	2007-05-21	Dissolved 2017-02-28
CAPITAL LAW AND PEOPLE LIMITED	WIMBLEDON TRUSTEES LIMITED	Company Secretary	2015-09-14	CURRENT	2007-04-19	Dissolved 2017-02-28
CAPITAL LAW AND PEOPLE LIMITED	PCI PHARMA MIDCO UK LIMITED	Company Secretary	2015-09-14	CURRENT	2014-07-28	Dissolved 2017-06-30
CAPITAL LAW AND PEOPLE LIMITED	PENN PHARMACEUTICALS LIMITED	Company Secretary	2015-09-14	CURRENT	2000-07-20	Dissolved 2018-04-03
CAPITAL LAW AND PEOPLE LIMITED	PENN PHARMACEUTICALS GROUP LIMITED	Company Secretary	2015-09-14	CURRENT	2004-09-16	Dissolved 2018-04-03
CAPITAL LAW AND PEOPLE LIMITED	BRECON HOLDINGS LIMITED	Company Secretary	2015-09-14	CURRENT	2006-02-15	Dissolved 2018-04-03
CAPITAL LAW AND PEOPLE LIMITED	BRECON PHARMACEUTICALS HOLDINGS LIMITED	Company Secretary	2015-09-14	CURRENT	2002-06-19	Dissolved 2018-04-03
CAPITAL LAW AND PEOPLE LIMITED	BIOTEC WORLDWIDE SUPPLIES GROUP LIMITED	Company Secretary	2015-09-14	CURRENT	2010-10-18	Dissolved 2018-04-03
CAPITAL LAW AND PEOPLE LIMITED	PCI UK HOLDCO LIMITED	Company Secretary	2015-09-14	CURRENT	2013-05-03	Dissolved 2018-04-03
CAPITAL LAW AND PEOPLE LIMITED	PENN PHARMA GROUP LIMITED	Company Secretary	2015-09-14	CURRENT	2007-01-08	Active
CAPITAL LAW AND PEOPLE LIMITED	PCI PENN UK HOLDCO LIMITED	Company Secretary	2015-09-14	CURRENT	2014-07-14	Active
CAPITAL LAW AND PEOPLE LIMITED	ANDERSONBRECON (UK) LIMITED	Company Secretary	2015-09-14	CURRENT	1990-09-27	Active
CAPITAL LAW AND PEOPLE LIMITED	BIOTEC SERVICES INTERNATIONAL LIMITED	Company Secretary	2015-09-14	CURRENT	1997-12-19	Active
MITCHELL ERIC BLUMENFELD	PENN LIMITED	Director	2016-07-01	CURRENT	2007-06-05	Dissolved 2017-02-28
MITCHELL ERIC BLUMENFELD	BIOTEC CLINICAL SUPPLIES LIMITED	Director	2016-07-01	CURRENT	2003-03-25	Dissolved 2017-02-28
MITCHELL ERIC BLUMENFELD	BIOTEC DISTRIBUTION, WALES LIMITED	Director	2016-07-01	CURRENT	2007-05-21	Dissolved 2017-02-28
MITCHELL ERIC BLUMENFELD	WIMBLEDON TRUSTEES LIMITED	Director	2016-07-01	CURRENT	2007-04-19	Dissolved 2017-02-28
MITCHELL ERIC BLUMENFELD	PCI PHARMA HOLDINGS UK LIMITED	Director	2016-07-01	CURRENT	2014-07-28	Dissolved 2017-06-30
MITCHELL ERIC BLUMENFELD	PCI PHARMA MIDCO UK LIMITED	Director	2016-07-01	CURRENT	2014-07-28	Dissolved 2017-06-30
MITCHELL ERIC BLUMENFELD	PENN PHARMACEUTICALS LIMITED	Director	2016-07-01	CURRENT	2000-07-20	Dissolved 2018-04-03
MITCHELL ERIC BLUMENFELD	PENN PHARMACEUTICALS GROUP LIMITED	Director	2016-07-01	CURRENT	2004-09-16	Dissolved 2018-04-03
MITCHELL ERIC BLUMENFELD	BRECON HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2006-02-15	Dissolved 2018-04-03
MITCHELL ERIC BLUMENFELD	BRECON PHARMACEUTICALS HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2002-06-19	Dissolved 2018-04-03
MITCHELL ERIC BLUMENFELD	BIOTEC WORLDWIDE SUPPLIES GROUP LIMITED	Director	2016-07-01	CURRENT	2010-10-18	Dissolved 2018-04-03
MITCHELL ERIC BLUMENFELD	PCI UK HOLDCO LIMITED	Director	2016-07-01	CURRENT	2013-05-03	Dissolved 2018-04-03
REMY HAUSER	PENN LIMITED	Director	2016-07-01	CURRENT	2007-06-05	Dissolved 2017-02-28
REMY HAUSER	BIOTEC CLINICAL SUPPLIES LIMITED	Director	2016-07-01	CURRENT	2003-03-25	Dissolved 2017-02-28
REMY HAUSER	WIMBLEDON TRUSTEES LIMITED	Director	2016-07-01	CURRENT	2007-04-19	Dissolved 2017-02-28
REMY HAUSER	PCI PHARMA HOLDINGS UK LIMITED	Director	2016-07-01	CURRENT	2014-07-28	Dissolved 2017-06-30
REMY HAUSER	PCI PHARMA MIDCO UK LIMITED	Director	2016-07-01	CURRENT	2014-07-28	Dissolved 2017-06-30
REMY HAUSER	PENN PHARMACEUTICALS LIMITED	Director	2016-07-01	CURRENT	2000-07-20	Dissolved 2018-04-03
REMY HAUSER	PENN PHARMACEUTICALS GROUP LIMITED	Director	2016-07-01	CURRENT	2004-09-16	Dissolved 2018-04-03
REMY HAUSER	BRECON HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2006-02-15	Dissolved 2018-04-03
REMY HAUSER	BRECON PHARMACEUTICALS HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2002-06-19	Dissolved 2018-04-03
REMY HAUSER	BIOTEC WORLDWIDE SUPPLIES GROUP LIMITED	Director	2016-07-01	CURRENT	2010-10-18	Dissolved 2018-04-03
REMY HAUSER	PCI UK HOLDCO LIMITED	Director	2016-07-01	CURRENT	2013-05-03	Dissolved 2018-04-03
REMY HAUSER	PENN PHARMA GROUP LIMITED	Director	2016-07-01	CURRENT	2007-01-08	Active
REMY HAUSER	ANDERSONBRECON (UK) LIMITED	Director	2016-07-01	CURRENT	1990-09-27	Active
REMY HAUSER	BIOTEC SERVICES INTERNATIONAL LIMITED	Director	2016-07-01	CURRENT	1997-12-19	Active
REMY HAUSER	PIONEER UK MIDCO 1 LIMITED	Director	2016-07-01	CURRENT	2016-06-01	Active
REMY HAUSER	PIONEER UK MIDCO 2 LIMITED	Director	2016-07-01	CURRENT	2016-06-02	Active
REMY HAUSER	PIONEER UK HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2016-06-02	Active
REMY HAUSER	PENN PHARMACEUTICAL SERVICES LIMITED	Director	2016-07-01	CURRENT	1977-09-26	Active
REMY HAUSER	VOYAGE CARE HOLDCO LIMITED	Director	2015-10-01	CURRENT	2014-07-21	Active
SUJIT JOHN	PENN LIMITED	Director	2016-07-01	CURRENT	2007-06-05	Dissolved 2017-02-28
SUJIT JOHN	BIOTEC DISTRIBUTION, WALES LIMITED	Director	2016-07-01	CURRENT	2007-05-21	Dissolved 2017-02-28
SUJIT JOHN	WIMBLEDON TRUSTEES LIMITED	Director	2016-07-01	CURRENT	2007-04-19	Dissolved 2017-02-28
SUJIT JOHN	PCI PHARMA HOLDINGS UK LIMITED	Director	2016-07-01	CURRENT	2014-07-28	Dissolved 2017-06-30
SUJIT JOHN	PCI PHARMA MIDCO UK LIMITED	Director	2016-07-01	CURRENT	2014-07-28	Dissolved 2017-06-30
SUJIT JOHN	PENN PHARMACEUTICALS LIMITED	Director	2016-07-01	CURRENT	2000-07-20	Dissolved 2018-04-03
SUJIT JOHN	PENN PHARMACEUTICALS GROUP LIMITED	Director	2016-07-01	CURRENT	2004-09-16	Dissolved 2018-04-03
SUJIT JOHN	BRECON HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2006-02-15	Dissolved 2018-04-03
SUJIT JOHN	BRECON PHARMACEUTICALS HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2002-06-19	Dissolved 2018-04-03
SUJIT JOHN	BIOTEC WORLDWIDE SUPPLIES GROUP LIMITED	Director	2016-07-01	CURRENT	2010-10-18	Dissolved 2018-04-03
SUJIT JOHN	PCI UK HOLDCO LIMITED	Director	2016-07-01	CURRENT	2013-05-03	Dissolved 2018-04-03
SUJIT JOHN	PCI PENN UK HOLDCO LIMITED	Director	2016-07-01	CURRENT	2014-07-14	Active
SUJIT JOHN	BIOTEC SERVICES INTERNATIONAL LIMITED	Director	2016-07-01	CURRENT	1997-12-19	Active
SUJIT JOHN	PENN PHARMACEUTICAL SERVICES LIMITED	Director	2016-07-01	CURRENT	1977-09-26	Active
SUJIT JOHN	PIONEER UK MIDCO 2 LIMITED	Director	2016-06-02	CURRENT	2016-06-02	Active
SUJIT JOHN	PIONEER UK HOLDINGS LIMITED	Director	2016-06-02	CURRENT	2016-06-02	Active
SUJIT JOHN	PIONEER UK MIDCO 1 LIMITED	Director	2016-06-01	CURRENT	2016-06-01	Active
WILLIAM T MITCHELL, III	PIONEER UK MIDCO 1 LIMITED	Director	2016-07-01	CURRENT	2016-06-01	Active
WILLIAM T MITCHELL, III	PIONEER UK HOLDINGS LIMITED	Director	2016-07-01	CURRENT	2016-06-02	Active
WILLIAM T MITCHELL, III	PENN LIMITED	Director	2015-05-12	CURRENT	2007-06-05	Dissolved 2017-02-28
WILLIAM T MITCHELL, III	WIMBLEDON TRUSTEES LIMITED	Director	2015-05-12	CURRENT	2007-04-19	Dissolved 2017-02-28
WILLIAM T MITCHELL, III	PENN PHARMACEUTICALS LIMITED	Director	2015-05-12	CURRENT	2000-07-20	Dissolved 2018-04-03
WILLIAM T MITCHELL, III	PENN PHARMACEUTICALS GROUP LIMITED	Director	2015-05-12	CURRENT	2004-09-16	Dissolved 2018-04-03
WILLIAM T MITCHELL, III	PENN PHARMA GROUP LIMITED	Director	2015-05-12	CURRENT	2007-01-08	Active
WILLIAM T MITCHELL, III	PENN PHARMACEUTICAL SERVICES LIMITED	Director	2015-05-12	CURRENT	1977-09-26	Active
WILLIAM T MITCHELL, III	BIOTEC CLINICAL SUPPLIES LIMITED	Director	2014-09-18	CURRENT	2003-03-25	Dissolved 2017-02-28
WILLIAM T MITCHELL, III	BIOTEC DISTRIBUTION, WALES LIMITED	Director	2014-09-18	CURRENT	2007-05-21	Dissolved 2017-02-28
WILLIAM T MITCHELL, III	BIOTEC WORLDWIDE SUPPLIES GROUP LIMITED	Director	2014-09-18	CURRENT	2010-10-18	Dissolved 2018-04-03
WILLIAM T MITCHELL, III	BIOTEC SERVICES INTERNATIONAL LIMITED	Director	2014-09-18	CURRENT	1997-12-19	Active
WILLIAM T MITCHELL, III	PCI PENN UK HOLDCO LIMITED	Director	2014-07-14	CURRENT	2014-07-14	Active
WILLIAM T MITCHELL, III	BRECON PHARMACEUTICALS HOLDINGS LIMITED	Director	2013-05-10	CURRENT	2002-06-19	Dissolved 2018-04-03
WILLIAM T MITCHELL, III	ANDERSONBRECON (UK) LIMITED	Director	2013-05-10	CURRENT	1990-09-27	Active
WILLIAM T MITCHELL, III	PCI UK HOLDCO LIMITED	Director	2013-05-03	CURRENT	2013-05-03	Dissolved 2018-04-03

More director information

Corporation Filing History

Companies House Filing History

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2018-04-03	GAZ2	FINAL GAZETTE: DISSOLVED EX-LIQUIDATED
2018-01-03	LIQ13	NOTICE OF FINAL ACCOUNT PRIOR TO DISSOLUTION IN MVL:LIQ. CASE NO.1
2017-04-27	4.70	DECLARATION OF SOLVENCY
2017-04-27	600	NOTICE OF APPOINTMENT OF LIQUIDATOR (VOLUNTARY)
2017-04-27	LRESSP	SPECIAL RESOLUTION TO WIND UP
2017-04-03	LATEST SOC	03/04/17 STATEMENT OF CAPITAL;GBP 1
2017-04-03	SH19	03/04/17 STATEMENT OF CAPITAL GBP 1.00
2017-04-03	SH20	STATEMENT BY DIRECTORS
2017-04-03	CAP-SS	SOLVENCY STATEMENT DATED 17/03/17
2017-04-03	RES09	AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL
2017-04-03	RES06	REDUCE ISSUED CAPITAL 17/03/2017
2016-12-14	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR MITCHELL ERIC BLUMENFELD / 13/12/2016
2016-12-14	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR SUJIT JOHN / 13/12/2016
2016-12-14	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR WILLIAM T MITCHELL, III / 13/12/2016
2016-12-13	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR REMY HAUSER / 13/12/2016
2016-12-13	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR REMY HAUSER / 13/12/2016
2016-11-08	TM01	APPOINTMENT TERMINATED, DIRECTOR TACHI YAMADA
2016-11-08	TM01	APPOINTMENT TERMINATED, DIRECTOR JOSEPH WHITTERS
2016-10-07	LATEST SOC	07/10/16 STATEMENT OF CAPITAL;GBP 247450
2016-10-07	CS01	CONFIRMATION STATEMENT MADE ON 26/09/16, WITH UPDATES
2016-07-15	AP01	DIRECTOR APPOINTED MR SUJIT JOHN
2016-07-15	AP01	DIRECTOR APPOINTED MR MITCHELL BLUMENFELD
2016-07-14	TM01	APPOINTMENT TERMINATED, DIRECTOR NATHAN EVERY
2016-07-14	AP01	DIRECTOR APPOINTED MR REMY HAUSER
2016-07-14	TM01	APPOINTMENT TERMINATED, DIRECTOR PHILLIP CUMMINS
2016-07-14	TM01	APPOINTMENT TERMINATED, DIRECTOR ALAN FRAZIER
2016-07-06	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 042941200007
2016-07-06	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 042941200004
2016-07-06	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 042941200006
2016-07-06	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 042941200005
2016-06-23	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 042941200008
2016-05-05	AD01	REGISTERED OFFICE CHANGED ON 05/05/2016 FROM UNITS 23-24 TAFARNAUBACH INDUSTRIAL ESTATE TAFARNAUBACH TREDEGAR GWENT NP22 3AA WALES
2016-04-11	AA	FULL ACCOUNTS MADE UP TO 30/06/15
2016-03-07	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR TACHI YAMADA / 07/03/2016
2016-01-13	AP01	DIRECTOR APPOINTED MR TACHI YAMADA
2016-01-06	TM01	APPOINTMENT TERMINATED, DIRECTOR WILLIAM WHATMORE
2015-10-27	AD02	SAIL ADDRESS CHANGED FROM: THE BROADGATE TOWER THIRD FLOOR 20 PRIMROSE STREET LONDON EC2A 2RS UNITED KINGDOM
2015-10-22	AD01	REGISTERED OFFICE CHANGED ON 22/10/2015 FROM C/O CAPITAL LAW LLP CAPITAL BUILDING TYNDALL STREET CARDIFF CF10 4AZ
2015-10-22	LATEST SOC	22/10/15 STATEMENT OF CAPITAL;GBP 247450
2015-10-22	AR01	26/09/15 FULL LIST
2015-10-13	AD01	REGISTERED OFFICE CHANGED ON 13/10/2015 FROM UNITS 23-24 TAFARNAUBACH INDUSTRIAL ESTATE TREDEGAR GWENT NP22 3AA
2015-09-14	AP04	CORPORATE SECRETARY APPOINTED CAPITAL LAW AND PEOPLE LIMITED
2015-08-07	TM02	APPOINTMENT TERMINATED, SECRETARY REED SMITH CORPORATE SERVICES LIMITED
2015-06-17	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 042941200008
2015-05-20	AP01	DIRECTOR APPOINTED WILLIAM STEPHEN L WHATMORE
2015-05-15	AP01	DIRECTOR APPOINTED PHILLIP CUMMINS
2015-05-15	TM01	APPOINTMENT TERMINATED, DIRECTOR PHILLIP CUMMINS
2015-05-15	AP01	DIRECTOR APPOINTED MR WILLIAM T MITCHELL, III
2015-05-15	AP01	DIRECTOR APPOINTED MR ALAN DAVID FRAZIER
2015-05-15	AP01	DIRECTOR APPOINTED MR NATHAN ROBERT EVERY
2015-05-15	AP01	DIRECTOR APPOINTED MR JOSEPH EDWARD WHITTERS
2015-05-14	TM01	APPOINTMENT TERMINATED, DIRECTOR RICHARD YARWOOD
2015-05-14	TM01	APPOINTMENT TERMINATED, DIRECTOR MARK DEAN-NETSCHER
2015-05-14	AP04	CORPORATE SECRETARY APPOINTED REED SMITH CORPORATE SERVICES LIMITED
2015-05-14	AP01	DIRECTOR APPOINTED PHILLIP CUMMINS
2015-03-27	AD03	REGISTER(S) MOVED TO SAIL ADDRESS 114-REG MEM 162-REG DIR 275-REG SEC 358-REC OF RES ETC 877-INST CREATE CHARGES:EW & NI
2015-03-27	AD02	SAIL ADDRESS CHANGED FROM: UNIT 23-24 TAFARNAUBACH INDUSTRIAL ESTATE TAFARNAUBACH TREDEGAR GWENT NP22 3AA
2014-11-14	TM01	APPOINTMENT TERMINATED, DIRECTOR CRAIG COLLINGWOOD
2014-11-14	TM02	APPOINTMENT TERMINATED, SECRETARY CRAIG COLLINGWOOD
2014-11-14	TM02	APPOINTMENT TERMINATED, SECRETARY CRAIG COLLINGWOOD
2014-11-14	TM01	APPOINTMENT TERMINATED, DIRECTOR CRAIG COLLINGWOOD
2014-10-20	LATEST SOC	20/10/14 STATEMENT OF CAPITAL;GBP 247450
2014-10-20	AR01	26/09/14 FULL LIST
2014-10-16	AA01	CURREXT FROM 31/03/2015 TO 30/06/2015
2014-08-14	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 042941200005
2014-08-14	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 042941200007
2014-08-14	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 042941200006
2014-08-14	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 042941200004
2014-08-13	AUD	AUDITOR'S RESIGNATION
2014-08-09	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE NO 2
2014-08-09	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 042941200003
2014-07-08	AA	FULL ACCOUNTS MADE UP TO 31/03/14
2014-01-08	MEM/ARTS	ARTICLES OF ASSOCIATION
2014-01-08	RES01	ALTER ARTICLES 18/12/2013
2014-01-08	RES13	RE-TRANSACTIONS DOCUMENTS 18/12/2013
2014-01-07	RES13	PROPOSED INTERIM DIVIDEND OF £8,800,000 BE APPROVED 20/12/2013
2013-12-20	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 042941200003
2013-11-08	AA	FULL ACCOUNTS MADE UP TO 31/03/13
2013-09-27	LATEST SOC	27/09/13 STATEMENT OF CAPITAL;GBP 247450
2013-09-27	AR01	26/09/13 FULL LIST
2012-10-12	AR01	26/09/12 FULL LIST
2012-10-12	AD02	SAIL ADDRESS CHANGED FROM: 2 TEMPLE BACK EAST TEMPLE QUAY BRISTOL BS1 6EG
2012-09-11	AA	FULL ACCOUNTS MADE UP TO 31/03/12
2012-04-24	AP01	DIRECTOR APPOINTED MR CRAIG COLLINGWOOD
2012-04-24	AP03	SECRETARY APPOINTED MR CRAIG COLLINGWOOD
2012-04-16	TM02	APPOINTMENT TERMINATED, SECRETARY LEE MAINWARING
2012-04-16	TM01	APPOINTMENT TERMINATED, DIRECTOR LEE MAINWARING
2011-10-04	AR01	26/09/11 FULL LIST
2011-09-02	AA	FULL ACCOUNTS MADE UP TO 31/03/11
2011-06-01	AP01	DIRECTOR APPOINTED MARK DEAN-NETSCHER
2011-02-02	TM01	APPOINTMENT TERMINATED, DIRECTOR DAVID COOPER
2011-01-12	AP01	DIRECTOR APPOINTED DAVID WILLIAM COOPER
2011-01-12	AP01	DIRECTOR APPOINTED RICHARD JOHN YARWOOD
2011-01-05	AA	FULL ACCOUNTS MADE UP TO 31/03/10
2011-01-04	TM01	APPOINTMENT TERMINATED, DIRECTOR PAUL THOMAS
2010-11-08	AR01	26/09/10 FULL LIST
2010-08-20	AD03	REGISTER(S) MOVED TO SAIL ADDRESS 114-REG MEM
2010-08-20	AD03	REGISTER(S) MOVED TO SAIL ADDRESS 877-INST CREATE CHARGES:EW & NI
2010-08-20	AD03	REGISTER(S) MOVED TO SAIL ADDRESS 275-REG SEC
2010-08-20	AD03	REGISTER(S) MOVED TO SAIL ADDRESS 162-REG DIR
2010-08-20	AD02	SAIL ADDRESS CREATED
2010-04-09	TM01	APPOINTMENT TERMINATED, DIRECTOR DARREN HASSEY
2010-02-10	TM01	APPOINTMENT TERMINATED, DIRECTOR PETER GEORGE
2010-01-16	AA	FULL ACCOUNTS MADE UP TO 31/03/09
2009-10-26	AR01	26/09/09 FULL LIST
2009-09-08	288a	DIRECTOR APPOINTED DARREN PETER HASSEY
2008-11-11	AA	FULL ACCOUNTS MADE UP TO 31/03/08
2008-10-02	363a	RETURN MADE UP TO 26/09/08; FULL LIST OF MEMBERS
2008-09-17	288c	DIRECTOR AND SECRETARY'S CHANGE OF PARTICULARS / LEE MAINWARING / 01/08/2008
2008-09-17	288c	DIRECTOR'S CHANGE OF PARTICULARS / PETER GEORGE / 01/08/2008
2008-05-02	288c	DIRECTOR'S CHANGE OF PARTICULARS / PAUL THOMAS / 01/04/2008
2007-12-20	AA	FULL ACCOUNTS MADE UP TO 31/03/07
2007-11-19	363a	RETURN MADE UP TO 26/09/07; FULL LIST OF MEMBERS
2007-08-01	288c	SECRETARY'S PARTICULARS CHANGED
2007-05-18	288a	NEW DIRECTOR APPOINTED
2007-05-18	288b	DIRECTOR RESIGNED
2007-05-18	288b	DIRECTOR RESIGNED
2007-05-18	288a	NEW DIRECTOR APPOINTED
2007-05-14	155(6)b	DECLARATION OF ASSISTANCE FOR SHARES ACQUISITION
2007-05-14	155(6)b	DECLARATION OF ASSISTANCE FOR SHARES ACQUISITION
2007-05-14	155(6)a	DECLARATION OF ASSISTANCE FOR SHARES ACQUISITION
2007-05-14	155(6)a	DECLARATION OF ASSISTANCE FOR SHARES ACQUISITION
2007-05-14	RES01	ALTERATION TO MEMORANDUM AND ARTICLES
2007-05-14	155(6)a	DECLARATION OF ASSISTANCE FOR SHARES ACQUISITION
2007-05-14	155(6)b	DECLARATION OF ASSISTANCE FOR SHARES ACQUISITION

Industry Information

SIC/NAIC Codes

21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

211 - Manufacture of basic pharmaceutical products

21100 - Manufacture of basic pharmaceutical products

Licences & Regulatory approval

We could not find any licences issued to PENN PHARMACEUTICALS HOLDINGS LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

Risks

Legal Notices

No legal notices or events such as winding-up orders or proposals to strike-off have been issued

Fines / Sanctions

No fines or sanctions have been issued against PENN PHARMACEUTICALS HOLDINGS LIMITED

Liabilities

Mortgages / Charges

Total # Mortgages/Charges	8
Mortgages/Charges outstanding	0
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	8

Details of Mortgagee Charges

Charge Type	Date of Charge	Charge Status	Mortgagee
	2015-06-15	Satisfied	BARCLAYS BANK PLC
	2014-08-14	Satisfied	ROYAL BANK OF CANADA
	2014-08-14	Satisfied	ROYAL BANK OF CANADA
	2014-08-14	Satisfied	ROYAL BANK OF CANADA
	2014-08-14	Satisfied	ROYAL BANK OF CANADA
	2013-12-20	Satisfied	HSBC BANK PLC AS AGENT AND TRUSTEE FOR THE SECURED PARTIES
DEBENTURE	2007-05-04	Satisfied	HSBC BANK PLC
DEBENTURE	2001-11-16	Satisfied	THE ROYAL BANK OF SCOTLAND PLC

Intangible Assets

Patents

We have not found any records of PENN PHARMACEUTICALS HOLDINGS LIMITED registering or being granted any patents

Domain Names

We do not have the domain name information for PENN PHARMACEUTICALS HOLDINGS LIMITED

Trademarks

We have not found any records of PENN PHARMACEUTICALS HOLDINGS LIMITED registering or being granted any trademarks

Income

Government Income

We have not found government income sources for PENN PHARMACEUTICALS HOLDINGS LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (21100 - Manufacture of basic pharmaceutical products) as PENN PHARMACEUTICALS HOLDINGS LIMITED are:

Outgoings

Business Rates/Property Tax

No properties were found where PENN PHARMACEUTICALS HOLDINGS LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

The council hasnt published the data
We havent found or been able to process the councils data
The company is part of a group of companies and another company in the group is liable for business rates
The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Legal Notices/Action

Initiating party		Event Type	Notices to Creditors
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type	Appointment of Liquidators
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type	Resolutions for Winding-up
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
On 5 April 2017 the above-named companies which have not traded for at least 12 months and whose registered office is at Capital Building, Tyndall Street, Cardiff CF10 4AZ, were placed into members voluntary liquidation and Emma Cray (office holder no: 17450) and Rob Lewis (office holder no: 9277) were appointed Joint Liquidators. The companies are presently expected to be able to pay their known liabilities in full. NOTICE IS HEREBY GIVEN, under Rule 4.182A of the Insolvency Rules 1986, that it is the intention of the Joint Liquidators to declare a first distribution to creditors in respect of the above-named companies of 100 pence in the pound within the period of 2 months from the last date for proving specified below. Creditors who have not yet done so are required, on or before 24 May 2017 (the last date for proving), to send their proofs of debt in writing to the undersigned Emma Cray of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT, the Joint Liquidator of the companies, and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to the Joint Liquidators to be necessary. It should be noted that, after the last date for proving, the Joint Liquidators intend to declare a distribution to the members, and will do so without further regard to creditors claims which were not proved by that date. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497. Emma Cray and Robert Nicholas Lewis , Joint Liquidators

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Emma Cray and Robert Nicholas Lewis of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT : Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Initiating party		Event Type
Defending party	PENN PHARMACEUTICALS HOLDINGS LIMITED	Event Date	2017-04-05
Notice is hereby given, as required by Section 85(1) of the Insolvency Act 1986, that resolutions have been passed by the Members on 5 April 2017 to wind up each of the above companies and appoint Liquidators as follows: Special resolution 1 THAT the Companies be wound up voluntarily. Ordinary resolution 2 THAT Emma Cray and Rob Lewis of PricewaterhouseCoopers LLP, 19 Cornwall Street, Birmingham B3 2DT be and are hereby appointed Joint Liquidators of the Companies for the purposes of each winding up, and any act required or authorised under any enactment to be done by the Joint Liquidators is to be done by all or any one or more of the persons for the time being holding office. Office Holder Details: Emma Cray and Robert Nicholas Lewis (IP numbers 17450 and 9277 ) of PricewaterhouseCoopers LLP , Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT . Date of Appointment: 5 April 2017 . Further information about this case is available from Amanda Lewis at the offices of PricewaterhouseCoopers LLP on 0121 265 5497.

Government Grants / Awards

Technology Strategy Board Awards

The Technology Strategy Board has not awarded PENN PHARMACEUTICALS HOLDINGS LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR

European Union CORDIS Awards

The European Union has not awarded PENN PHARMACEUTICALS HOLDINGS LIMITED any grants or awards.

Ownership

We could not find any group structure information

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Need more information?

We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.

Last Datalog update:	2018-05-13 08:59:06
Primary Source:	Companies House

Company Overview

Company Officers of PENN PHARMACEUTICALS HOLDINGS LIMITED

Related Directorships